_:ndb8cabbc70854cd7add219f634fd6c1bxb0
<http://schema.org/mainEntityOfPage>
<https://business.dptribune.com/dptribune/article/gnwcq-2024-5-22-kymera-therapeutics-presents-new-preclinical-data-for-kt-621-a-first-in-class-oral-stat6-degrader-at-the-ats-annual-meeting>